Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease.
about
Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factorsLong-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events.
P2860
Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Renal function predicts long-t ...... n patients with Fabry disease.
@en
Renal function predicts long-t ...... n patients with Fabry disease.
@nl
type
label
Renal function predicts long-t ...... n patients with Fabry disease.
@en
Renal function predicts long-t ...... n patients with Fabry disease.
@nl
prefLabel
Renal function predicts long-t ...... n patients with Fabry disease.
@en
Renal function predicts long-t ...... n patients with Fabry disease.
@nl
P2093
P2860
P356
P1476
Renal function predicts long-t ...... n patients with Fabry disease.
@en
P2093
Christine Kurschat
Jörg Stypmann
Malte Lenders
Stefan-Martin Brand
Thomas Duning
P2860
P304
P356
10.1093/NDT/GFW334
P407
P577
2016-09-27T00:00:00Z